Back to search

Article

Predictive Biomarkers for the Responsiveness of Recurrent Glioblastomas to Activated Killer Cell Immunotherapy

2022-09-23

Abstract excerpt

<h4>Background</h4> Recurrent glioblastoma multiforme (GBM) is a highly aggressive primary malignant brain tumor that is resistant to existing treatments. Recently, we reported that activated autologous natural killer (NK) cell therapeutics induced a marked increase in survival of some patients with recurrent GBM. <h4>Methods</h4> To identify biomarkers that predict responsiveness to NK therapeutics, we examined i...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2ac67411-a275-5990-b186-83fa2cae320a
DOI
10.1101/2022.09.21.22280225
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Predictive Biomarkers for the Responsiveness of Recurrent Glioblastomas to Activated Killer Cell ImmunotherapyDOI 10.1101/2022.09.21.22280225
Expression profiling of single cells and patient cohorts identifies multiple immunosuppressive pathways and an altered NK cell phenotype in glioblastoma.Semantic proximity
Immune-related lncRNAs signature and radiomics signature predict the prognosis and immune microenvironment of glioblastoma multiformeSemantic proximity
Expression profiling of single cells and patient cohorts identifies multiple immunosuppressive pathways and an altered NK cell phenotype in glioblastomaSemantic proximity
Tumor-infiltrating CD8+ sub-populations in primary and recurrent glioblastoma: An in-silico studySemantic proximity
Multidimensional analysis of matched primary and recurrent glioblastoma identifies Fcγ receptors upregulation on microglia as a contributor of tumor recurrenceSemantic proximity
Inhibition of the αv integrin-TGF-β axis improves natural killer cell function against glioblastoma stem cellsSemantic proximity
Expression Profiling of Primary and Recurrent Glioblastomas Reveals a Reduced Level of Pentraxin 3 in Recurrent GlioblastomasSemantic proximity
Innate Immune Receptor NLRX1: Potential Modulator of Glioblastoma PathophysiologySemantic proximity
Long-term survival after local immunotherapy for malignant gliomas: a retrospective study with 20 years follow-up.Semantic proximity
Fc gamma receptor IIb in tumor-associated macrophages and dendritic cells drives poor prognosis of recurrent glioblastoma through immune-associated signaling pathwaysSemantic proximity
Combination of Immunotherapy and Radiotherapy for Recurrent Malignant Gliomas: Results From a Prospective Study.Semantic proximity
The immune-related microRNA miR-146b is upregulated in glioblastoma recurrenceSemantic proximity
Select a neighboring publication to make it the new centre.